Universal Omics
Universal Omics is a biotechnology company specializing in fast-track drug discovery and design for non-communicable diseases (NCDs) caused by malnutrition, using its proprietary in-silico software, DRUP. The company aims to reduce pre-clinical drug development time by up to 60%. Universal Omics addresses the high costs and low success rates of traditional drug development by leveraging AI and quantum computing for biomarker discovery, target identification, nutraceutical and drug design, and predicting drug efficacy and safety. Their platform integrates big data to provide personalized clinical and nutritional interventions, focusing on areas like cardiac disease, obesity, diabetes, and immunity. They emphasize democratizing data use and guaranteeing product effectiveness and quality with minimal risk of side effects.
Universal Omics
Universal Omics is a biotechnology company specializing in fast-track drug discovery and design for non-communicable diseases (NCDs) caused by malnutrition, using its proprietary in-silico software, DRUP. The company aims to reduce pre-clinical drug development time by up to 60%. Universal Omics addresses the high costs and low success rates of traditional drug development by leveraging AI and quantum computing for biomarker discovery, target identification, nutraceutical and drug design, and predicting drug efficacy and safety. Their platform integrates big data to provide personalized clinical and nutritional interventions, focusing on areas like cardiac disease, obesity, diabetes, and immunity. They emphasize democratizing data use and guaranteeing product effectiveness and quality with minimal risk of side effects.